Trials / Conditions / Triple Negative Breast Cancer Metastatic

Triple Negative Breast Cancer Metastatic

3 registered clinical trials studyying Triple Negative Breast Cancer Metastatic — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Phase 2 Clinical Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Platinum Chemotherapy Vers NCT07413601	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	Phase 2
Recruiting	A Phase II Clinical Study of Multimodal Ablation Combined With Systemic Drug Therapy for Advanced Solid Tumors NCT06889610	Fudan University	Phase 2
Recruiting	Restoring Sensitivity To Immunotherapy In Advanced Triple Negative Breast Cancer Exploiting Ceralasertib Primi NCT05582538	IFOM ETS - The AIRC Institute of Molecular Oncology	Phase 2